Two ORFs encoding Lnt are found in M. bovis BCG (BCG_2070c, BCG_2279c). BCG_2070c (which is identical to M. tuberculosis Rv2051c = ppm1) is a two domain protein
with a conserved apolipoprotein-N-acyltransferase and a Ppm-like domain. BCG_2279c shows conserved apolipoprotein-N-acyltransferase domain and exhibits considerable homology to E. coli Lnt. In M. tuberculosis, the corresponding open reading frame is split into two, Rv2262c and Rv2261c. In our previous analysis [12], these may have escaped our attention, since split. Only upon completion of the M. bovis BCG sequence the homology to Lnt became apparent. Due to this polymorphism in the second M. tuberculosis putative Lnt ORF, we focussed our studies on lipoproteins and lipoprotein synthesis in slow-growing mycobacteria on the vaccine strain M. bovis BCG. Prediction FG4592 of lipoproteins in M. tuberculosis complex using DOLOP database suggests the presence of 50 potential lipoproteins of the approximately 4000 ORFs [2]. However, the existence of twice as many lipoproteins has been discussed [1]. In this study, we show that lipoproteins are triacylated in slow-growing M. bovis Elafibranor datasheet BCG. We demonstrate apolipoprotein N-acyltransferase acitivity and by targeted gene deletion identify BCG_2070c as a functional Lnt. We give structural information
about the lipid modification of four mycobacterial lipoproteins, LprF, LpqH, LpqL and LppX. Hereby mycobacteria-specific tuberculostearic acid is identified as a further substrate for N-acylation. Methods Bacterial strains and growth conditions Mycobacterium bovis BCG Pasteur strains were cultivated in Middlebrook 7H9 medium or on Middlebrook 7H10 agar enriched with oleic acid albumin dextrose (OADC, Difco). Liquid broth was supplemented with 0.05% of Tween 80 to avoid clumping. If necessary, the appropriate antibiotic was added at Atorvastatin the following concentration: 5 μg ml-1 gentamicin, 100 μg ml-1 streptomycin, 25 μg ml-1 hygromycin. Strains used in this study were M. bovis BCG SmR (further referred to as M. bovis BCG or parental strain)
[31], a streptomycin resistant derivative of M. bovis BCG Pasteur 1173P2, Δlnt = M. bovis BCG SmR lnt knock out mutant in BCG_2070c and Δlnt-lntBCG_2070c = M. bovis BCG SmR lnt knock out mutant in BCG_2070c transformed with complementing vector pMV361-hyg-lntBCG_2070c. Disruption of lnt in M. bovis BCG A 1.9 kbp MluI/NsiI fragment of M. bovis BCG from position 2296156 to 2294306 comprising the 5’lnt flanking sequence and a 2.8 kbp SnaBI/MluI fragment from position 2292652 to 2289856 comprising the 3’lnt flanking sequence of the lnt domain of BCG_2070c were PCR amplified using genomic DNA from M. bovis BCG Pasteur and cloned into vector pMCS5-rpsL-hyg with the respective enzymes resulting in knock-out vector pMCS5-rpsL-hyg-ΔlntBCG. This way, we deleted a 1.